Clinical Trial

Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracerebral Hemorrhage at the Early Stage.

Study acronym: HEMS
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this trial is to investigate whether neuroendoscopic hematoma evacuation combined with early use of methylprednisolone sodium succinate can improve the efficacy and safety in the treatment with that of simple neuroendoscopic surgery alone for patients with spontaneous lobar intracerebral hemorrhage within 24 hours after the onset.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-09.
Trial Details
NCT Number NCT06921616
Lead Sponsor Yong Jiang
Conditions Stroke, Intracerebral Hemorrhage Lobar, Methylprednisolone, Surgery
Enrollment 396 participants
Start Date 2025-05-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-13